The dual role of ferroptosis in anthracycline-based chemotherapy includes reducing resistance and increasing toxicity

Authors:

Abstract
In conjunction with previous studies, we have noted that ferroptosis, as an emerging mode of regulated cell death (RCD), is intimately related to anthracycline pharmacotherapy. Not only does ferroptosis significantly modulate tumour resistance and drug toxicity, which are core links of the relevant chemotherapeutic process, but it also appears to play a conflicting role that has yet to be appreciated. By targeting the dual role of ferroptosis in anthracycline-based chemotherapy, this review aims to focus on the latest findings at this stage, identify the potential associations and provide novel perspectives for subsequent research directions and therapeutic strategies.
Funding Information
  • Industry-University-Research Innovation Fund of the Science and Technology Development Center, Ministry of Education, China
  • Hebei Natural Science Foundation

This publication has 153 references indexed in Scilit: